Načítá se...
IL-11 Is Required for A(1) Adenosine Receptor–Mediated Protection against Ischemic AKI
A(1) adenosine receptor activation ameliorates ischemic AKI through the induction of renal proximal tubular sphingosine kinase-1. However, systemic adverse effects may limit A(1) adenosine receptor–based therapy for ischemic AKI, indicating a need to identify alternative therapeutic targets within t...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Nephrology
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3785280/ https://ncbi.nlm.nih.gov/pubmed/23813214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013010114 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|